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A case history is presented of a middle-age patient with a rare cause of haemoptysis presenting as
a pulmonary mass associated with mediastinal lymphadenopathy. Surgical resection demonstrated
sclerosing (or ﬁbrosing) mediastinitis, a condition uncommon outside areas of endemic fungal infection.
We describe a case whereby an FDG-PET scan showed avid uptake of signal highly suspicious of cancer.
 2009 Elsevier Ltd. All rights reserved.1. History
A 44-year-old male smoker with a 36 pack year history of
smoking presented acutely with a brisk haemoptysis. There was no
history of pulmonary tuberculosis or a prior respiratory history. He
did not have a cough, pleuritic chest pain, weight loss or night
sweats, or history of domestic animal bites or exotic travel.
Oxygenation in room air was normal and general and respiratory
examination was unremarkable. Routine haematology, biochem-
istry, inﬂammatory markers and coagulation proﬁle were similarly
normal. The chest radiograph showedprominenceof the righthilum
with no evidence of a consolidation. A computed tomography (CT)
scan showed a 2.5 cm mass lying medially in the right upper lobe,
with a further mass immediately below this at the right hilum,
measuring approximately 3 cm. Several small (<1 cm) peripheral
pulmonary noduleswere also noted, withminor enlargement of the
right paratracheal and subcarinal nodes (see Fig. 1a,b).
A bronchoscopy showed mucosal distortion of the right
upper lobe with no evidence of tumour macroscopically or on
bronchial brush cytology. Microbiological culture of bronchial
lavage was sterile including mycobacteria. Several weeks
later, the haemoptysis had settled but the chest radiograph
remained unchanged so he underwent a rigid bronchoscopy and, North Bristol Lung Centre,
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rved.mediastinoscopy. Again, no new endobronchial abnormality was
visible and there was now no evidence of tracheal lymphade-
nopathy. The patient remained well with no further haemopt-
yses over the next 3 months, at which stage a repeat CT scan
showed no progression in the mass or mediastinal lymphade-
nopathy and, as EBUS was not available locally, a further repeat
bronchoscopy was performed, conﬁrming mucosal erythema
and distortion. Further multiple bronchial biopsies showed no
evidence of neoplasia and bronchial lavage was again sterile on
microbiological culture. A PET (Positron Emission Tomography)
CT scan was performed using ﬂuorine-18 ﬂuorodeoxyglucose (F-
18 FDG). This demonstrated signiﬁcantly increased activity at
the right hilum congruent with the right hilar mass, but the
mass had not increased signiﬁcantly in size from the earlier CT
scan (Fig. 2). As the patient had remained stable, he did not wish
to consider a further thoracoscopy or thoracotomy.
Three months later he re-presented with further episodes of
haemoptysis and so he agreed to proceed to a right thoracotomy
and resection. The lesion was not fully resectable, and he
continued to have signiﬁcant bleeding and haemoptyses in the
operative period. Control of bleeding was not possible without
proceeding to a right pneumonectomy. This controlled both his
symptoms, bleeding and he had no further haemoptyses.
Histological examination of the resected mass and lymph nodes
showed inﬁltration by dense hyalinised ﬁbrous tissue with chronic
inﬂammation and giant cells. There was no evidence of malignancy
within the mass or the lymph nodes. The features were consistent
with sclerosing mediastinitis (see Fig. 3). Subsequent serological
examination did not show evidence of fungal infection.
Fig. 2. The CT image shows soft tissue thickening around the right hilum compatible with e
same area.
Fig. 1. (a) and (b): Lung and mediastinal windows respectively, from a staging-protocol
CT scan.
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Sclerosing (or ﬁbrosing) mediastinitis is a rare but benign
disorder characterized by inﬂammation and dense ﬁbrosis of
mediastinal structures, and is associated with a variety of clinical
syndromes. The cause is probably an abnormal ﬁbroproliferative
response to an inﬂammatory stimulus, most commonly seen after
a granulomatous infection secondary to the fungus Histoplasma
capsulatum. It is also associated with other idiopathic ﬁbrotic
diseases, such as sclerosing cholangitis, Reidels thyroiditis and
retroperitoneal ﬁbrosis. Rarely, it has been described in association
with autoimmune disease, Behcets disease, tuberculosis, malig-
nancy and after radiation therapy..1–3 The inﬂammatory stimulus
leads to encasement of mediastinal structures within a dense
ﬁbrotic mass, arising from an invasive chronic inﬂammatory
process causing erosion as well as external compression of struc-
tures such as the superior vena cava, pulmonary veins or arteries,
central airways, or oesophagus, leading to different clinical symp-
toms such as dyspnoea, dysphagia or haemoptysis, or on occasion is
asymptomatic.3 It can masquerade as thoracic cancer in countries
outside endemic fungal infection areas, including Europe.
A spectrum of focal and diffuse ﬁbrosing mediastinitis is recog-
nised; diffuse mediastinitis presents as an inﬁltrating, often non-
calciﬁedmass that affects multiple mediastinal compartments while
the localized form leads to a calciﬁed mass in the paratracheal or
subcarinal areas of the mediastinum or in the pulmonary hila. In
milder forms of the disorder the chest X-ray can be unremarkable. In
progressive disease, both computed tomographic (CT) or magnetic
resonance (MR) imaging can deﬁne the extent of disease althoughnlarged lymph nodes, and the PET image shows a ‘hot’ spot of avid FDG uptake in the
Fig. 3. (a) and (b) respectively show a haemotoxylin and eosin-stained high power
photomicrograph of dense hyalinised ﬁbrous tissue with chronic inﬂammation and
adjacent lung parenchyma (3a) and the dense collagenous tissue extending into a hilar
node and surrounding airways and vascular channels at the hilum (3b).
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imaging modalities.4
The diagnosis of sclerosing mediastinitis in endemic areas
involves identifying Histoplasma by microbial culture (but this is
costly and time-consuming) or by serological response, but even
this approach is associated with false-positive results in individuals
from endemic areas without the disorder, and false negativesresults in those with compromised immune function. A positive
delayed hypersensitivity skin test also cannot discriminate
between past or current infection. As the disorder is associatedwith
other clinical entities in the absence of Histoplasma infection,
a surgical biopsy is usually required. Consequently the oral anti-
fungal agent ketoconazole is useful in patients with proven Histo-
plasma infection,5 but often as an adjunct to surgery which is
required initially for diagnosis, to rule out cancer and to treat the
complications. The extent of invasion of mediastinal structures
determines surgical success, and procedures such as superior vena
caval reconstruction, tracheal or oesophageal decompression,
lobectomy, division of tracheo-esophageal ﬁstulae or rarely
a pneumonectomy are required.6 Oral corticosteroid therapy has
been proven to be useful in selected cases.7,83. Conclusion
Sclerosing mediastinitis is rare in Europe but should be
considered in patients with a lung or mediastinal mass of unknown
aetiology. Surgical intervention is often required to make the
diagnosis and, in some cases to control symptoms and treat
complications. Medical treatment should also be considered,
particularly if there is conﬁrmed Histoplasmosis. The long-term
prognosis is variable depending on the extent of mediastinal
involvement and outcome of surgical treatment of complications.
Overall it is good if not associated with a malignancy.
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